Literature DB >> 27434861

The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-κB.

Gui Zhao1, Zhenyi Su1, Dan Song1, Yimin Mao1,2, Xiaohua Mao1.   

Abstract

MALAT1 is a conserved long noncoding RNA whose expression correlates with many human cancers. However, its significance in immunity remains largely unknown. Here, we observe that MALAT1 is upregulated in lipopolysaccharide (LPS)-activated macrophages. Knockdown of MALAT1 increases LPS-induced expression of TNFα and IL-6. Mechanistically, MALAT1 was found to interact with NF-κB in the nucleus, thus inhibiting its DNA binding activity and consequently decreasing the production of inflammatory cytokines. Additionally, abnormal expression of MALAT1 was found to be NF-κB-dependent. These findings suggest that MALAT1 may function as an autonegative feedback regulator of NF-κB to help fine-tune innate immune responses.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  MALAT1; Macrophage; NF-κB transcription factor; inflammation; innate immunity

Mesh:

Substances:

Year:  2016        PMID: 27434861     DOI: 10.1002/1873-3468.12315

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  73 in total

Review 1.  Long non-coding RNA: a versatile regulator of the nuclear factor-κB signalling circuit.

Authors:  Xiaohua Mao; Zhenyi Su; Adnan K Mookhtiar
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

Review 2.  The emergence of noncoding RNAs as Heracles in autophagy.

Authors:  Jian Zhang; Peiyuan Wang; Lin Wan; Shouping Xu; Da Pang
Journal:  Autophagy       Date:  2017-04-25       Impact factor: 16.016

3.  Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.

Authors:  David J Voce; Giovanna M Bernal; Longtao Wu; Clayton D Crawley; Wei Zhang; Nassir M Mansour; Kirk E Cahill; Szymon J Szymura; Abhineet Uppal; David R Raleigh; Ruben Spretz; Luis Nunez; Gustavo Larsen; Nikolai N Khodarev; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cancer Res       Date:  2019-04-02       Impact factor: 12.701

4.  Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke.

Authors:  Xuejing Zhang; Xuelian Tang; Kai Liu; Milton H Hamblin; Ke-Jie Yin
Journal:  J Neurosci       Date:  2017-01-16       Impact factor: 6.167

5.  LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever.

Authors:  Zhihua Li; Liang Xu; Yong Liu; Shaokun Fu; Jianhong Tu; Yangyang Hu; Qiuyun Xiong
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

Review 6.  Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases.

Authors:  Subash C Gupta; Nikee Awasthee; Vipin Rai; Srinivas Chava; Venugopal Gunda; Kishore B Challagundla
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-19       Impact factor: 10.680

Review 7.  The long noncoding RNA Malat1: Its physiological and pathophysiological functions.

Authors:  Xuejing Zhang; Milton H Hamblin; Ke-Jie Yin
Journal:  RNA Biol       Date:  2017-10-06       Impact factor: 4.652

8.  LncRNA Malat1 inhibition of TDP43 cleavage suppresses IRF3-initiated antiviral innate immunity.

Authors:  Wei Liu; Ziqiao Wang; Lun Liu; Zongheng Yang; Shuo Liu; Zhongfei Ma; Yin Liu; Yuanwu Ma; Lianfeng Zhang; Xuan Zhang; Minghong Jiang; Xuetao Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-09       Impact factor: 11.205

9.  Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells.

Authors:  Joshua K Stone; Jung-Hyun Kim; Lana Vukadin; Alexander Richard; Hannah K Giannini; Ssang-Taek Steve Lim; Ming Tan; Eun-Young Erin Ahn
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

Review 10.  Long non-coding RNAs regulating macrophage functions in homeostasis and disease.

Authors:  Kaitlyn R Scacalossi; Coen van Solingen; Kathryn J Moore
Journal:  Vascul Pharmacol       Date:  2018-03-13       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.